Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Hilal Bashir, PhD
Chronic stress is increasingly recognized as a significant factor exacerbating various chronic illnesses, including cancer and autoimmune… -
CRI Funded Scientist
Ghamdan Al-Eryani, PhD
Modeling the complexities of cancer ecosystems is crucial for developing effective cancer treatments, particularly for advancing personalized… -
CRI Funded Scientist
Francesca Smylie Gazzaniga, PhD
Immune checkpoint inhibitors (ICI) are standard treatment for more than 20 tumor types, yet only 20% of… -
CRI Funded Scientist
Felipe Silva Rodrigues, PhD
Our skin serves as a protective barrier against various threats like injuries and infections. For it to… -
CRI Funded Scientist
Elise Alspach, PhD
In this proposal, Dr. Alspach investigates the relationship between obesity, sex, and the efficacy of immune checkpoint… -
CRI Funded Scientist
Chinaemerem U. Onyishi, PhD
Antigen presentation is a process where foreign particles, such as pathogens, cancers, and allergens, are displayed to… -
CRI Funded Scientist
Ahmad Yatim, MD, PhD
Cutaneous squamous cell carcinomas (cSCC) are among the most common cancers, with a 100-fold increased risk in… -
CRI Funded Scientist
Mark A. Sellmyer, MD, PhD
Dr. Mark A. Sellmyer’s interdisciplinary approach combines molecular imaging with chemical biology to create innovative diagnostic and… -
CRI Funded Scientist
Stacy Malaker, PhD
Dr. Stacy Malaker’s laboratory is pioneering the field of “mucinomics,” creating advanced techniques to analyze abnormal glycosylation—…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.